Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Atto Bioscience

1985 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
Description

Developer of novel technologies for investigating biochemical and physiological changes in living cells in real time. The company develops, manufactures and markets products enabling real-time kinetic and structural analysis of biological reactions taking place in individual living cells.

Formerly Known As
Atto Instruments
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 15010 Broschart Road
  • Rockville, MD 20850
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Atto Bioscience’s full profile, request a free trial.

Atto Bioscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Jul-2004 $25M 000 0000 Completed Generating Revenue
2. Grant 00000 000 Completed Generating Revenue
1. Later Stage VC (Series A) 29-Oct-2001 $3M $3M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Atto Bioscience Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Defense Advanced Research Projects Agency Government 000 0000 000000 0
Emerging Technology Partners Venture Capital Minority 000 0000 000000 0

Atto Bioscience Executive Team (4)

Name Title Board
Seat
Contact
Info
Gloria Zak Chief Financial Officer
Gary Brooker Ph.D Co-Founder & Chief Scientific Officer
Jeff Brooker Co-Founder
Derek Woods Ph.D Chief Executive Officer & President